Ghrelin, atherosclerosis, and glucose: Gag or causal relationships?

Transplantation

Volumn 84, Issue 10, 2007, Pages 1220-1221

  Hjelmesæth, Jøran ^a,b   Jenssen, Trond ^b,c   Hartmann, Anders ^b  

^a VESTFOLD HOSPITAL TRUST   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CYCLOSPORIN A; GHRELIN; GLUCOCORTICOID; GLUCOSE; TACROLIMUS;

ABDOMINAL OBESITY; ATHEROSCLEROSIS; CLINICAL TRIAL; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; METABOLIC SYNDROME X; NEW ONSET DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; BIOLOGICAL MODEL; BLOOD; CARDIOVASCULAR DISEASE; IMPAIRED GLUCOSE TOLERANCE; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ATHEROSCLEROSIS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GHRELIN; HUMANS; MODELS, BIOLOGICAL; OBESITY; PREDIABETIC STATE; RISK FACTORS;

EID: 38449115204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000287429.29273.ca     Document Type: Note

References (9)

1. de Vries AP, Bakker SJ, van Soon WJ, et al. Metabolic syndrome is associated with impaired long-term renal allograft function; Not all component criteria contribute equally. Am J Transplant 2004; 4: 1675.
2. Hjelmesæth J, Hartmann A, Midtvedt K, et al. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001; 16: 1047.
3. Courivad C, Kazory A, Simula-Faivre D, et al. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007; 83: 1577.
4. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506.
5. Hjelmesæth J, Hartmann A, Leivestad T, et al. The impact of early diagnosed new-onset posttransplantation diabetes mellitus on longterm survival and major cardiac events. Kidney Int 2006; 69: 588.
6. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25. 426.
7. Hjelmesæth J, Flyvbjerg A, Jenssen T, et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol 2006; 1: 575.
8. Armstrong KA, Hiremagulur B, Haluska BA, et al. Free fatty acids are associated with obesity, insulin resistance and atherosclerosis in renal transplant recipients. Transplantation 2005; 80: 937.
9. Poykko SM, Kellokoski E, Ukkola O, et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 2006; 260: 43.